Sleep Apnea Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Polysomnography (PSG) Device, Home Sleep Testing Devices, Oximeter, Actigraphy Monitoring Device, and Sleep Apnea Screening Device], and End User (Hospitals and Sleep Laboratories, and Home Care Settings), and Geography
Publication Month: Nov 2021 | Report Code: TIPRE00016809 | No. of Pages: 166 | Category: Medical Device | Status: Published
The sleep apnea diagnostics market is projected to reach US$ 685.66 million by 2028 from US$ 473.95 million in 2021; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028
Sleep apnea is a common type of sleep disorder that happens when an individual is having trouble in breathing during sleep where breathing repeatedly stops and starts. Sleep apnea devices are primarily provided as diagnostic and therapeutic devices in order to treat obstructive sleep apnea syndrome, central sleep apnea syndrome and complex sleep apnea syndrome. Continuous positive airway pressure is widely recommended device to treat obstructive sleep apnea.
Strategic Insights
Factors such as increased sleep apnea prevalence, technological developments, and rising geriatric population are boosting the sleep apnea diagnostics market growth. However, the high cost of diagnosis, and challenges in medical device industry hamper the growth of the market.
Lucrative Regions for Sleep Apnea Diagnostics Market
Get more information on this report :
Market Insights
Increased Prevalence of Sleep Apnea Boosts Sleep Apnea Diagnostics Market Growth
Obstructive sleep apnea (OSA) is a common disorder, characterized by the repetitive, complete or partial closure of the upper airway during sleep. This airway is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in the form of impairment of daytime functioning and degraded quality of life. As per recent controlled trials, oral appliances are up to 50.0% efficient in controlling the OSA among patients, including severe cases.
According to a survey conducted by Needham & Company, an investment firm, over one-third of OSA tests were conducted in patients' homes in 2018, up from 15% in 2013. As a result, companies are concentrating their efforts on the development of home-care sleep apnea equipment. In June 2019, the FDA approved Itamar Medical, an Israel-based business, for a disposable home sleep apnea test. ResApp (Australia), a firm that develops smartphone applications for the diagnosis and management of respiratory disorders, has launched SleepCheck, an at-home screening app for the OSA.
Due to the rising use of the polysomnography (PSG) device in the various regions, the need for improved and technologically advanced PSG devices for the diagnosis of OSA has surged substantially, thus driving the global sleep apnea diagnostics market.
Product and Service-Based Insights
Based on product, the sleep apnea diagnostics market is segmented into polysomnography (PSG) device, home sleep testing devices, oximeter, actigraphy monitoring device, and sleep apnea screening device. The oximeter segment is further segmented into fingertip oximeter, handheld oximeter, wrist-worn oximeter, and tabletop oximeter. The PSG device segment is expected to hold the largest share of the market in 2021, and it is further expected to register the highest CAGR during the forecast period.
Sleep Apnea Diagnostics Market, by Product – 2021 and 2028
Get more information on this report :
End-User -Based Insights
Based on end-user, the sleep apnea diagnostics market is segmented into hospitals and sleep laboratories, and home care settings. The hospitals and sleep laboratories segment is expected to hold a larger market share in 2021, whereas the home care settings segment is expected to register a higher CAGR in the market during the forecast period
Various companies operating in the sleep apnea diagnostics market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.
Sleep Apnea Market – by Product
- Polysomnography (PSG) Device
- Home Sleep Testing Devices
- Oximeter
- Fingertip Oximeter
- Hand held oximeter
- Wrist-Worn Oximeter
- Tabletop Oximeter
- Actigraphy Monitoring Device
- Sleep Apnea Screening Device
Sleep Apnea Diagnostics Market – by End User
- Hospital and sleep laboratories
- Home Care Settings
Sleep Apnea Diagnostics Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
- South America (SAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Drive DeVilbiss International
- ResMed Inc.
- Nihon Kohden Corporation
- SOMNOmedics GmbH
- Cleveland Medical Devices Inc
- Koninklijke Philips N.V.
- Cadwell Industries Inc
- Natus Medical Incorporated
- Itamar Medical Ltd.
- Compumedics Limited
Frequently Asked Questions
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sleep apnea diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global sleep apnea diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount